Refine
Has Fulltext
- yes (278)
Year of publication
Document Type
- Journal article (167)
- Doctoral Thesis (97)
- Complete part of issue (10)
- Conference Proceeding (3)
- Preprint (1)
Language
- English (159)
- German (116)
- Multiple languages (3)
Keywords
- multiple sclerosis (11)
- Endothel (9)
- Multiple Sklerose (9)
- EAE (8)
- B cells (7)
- Habichtskraut (7)
- Geobotanik (6)
- MS (6)
- Pemphigus (6)
- Pflanzengeographie (6)
Institute
- Institut für Anatomie und Zellbiologie (278) (remove)
Sonstige beteiligte Institutionen
- Department of Biomedical Imaging, National Cerebral and Cardiovascular Research Center, Suita, Japan (2)
- Division of Medical Technology and Science, Department of Medical Physics and Engineering, Course of Health Science, Osaka University Graduate School of Medicine, Suita Japan (2)
- Institut for Molecular Biology and CMBI, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Leopold-Franzens-University Innsbruck, Innsbruck, Austria (2)
- Johns Hopkins School of Medicine, The Russell H Morgan Department of Radiology and Radiological Science, Baltimore, MD, USA (2)
- Naturalis Biodiversity Centre (2)
- Johns Hopkins School of Medicine (1)
- Johns Hopkins School of Medicine, Baltimore, MD, U.S. (1)
Energy demand of neurons in brain that is covered by glucose supply from the blood is ensured by glucose transporters incapillaries and brain cells. In brain, the facilitative diffusion glucose transporters GLUT1-6 and GLUT8, and the Na+-D-glucosecotransporters SGLT1 are expressed. The glucose transporters mediate uptake of D-glucose across the blood-brain barrier anddelivery of D-glucose to astrocytes and neurons. They are critically involved in regulatory adaptations to varying energy demandsin response to differing neuronal activities and glucose supply. In this review, a comprehensive overview about verified andproposed roles of cerebral glucose transporters during health and diseases is presented. Our current knowledge is mainly based onexperiments performed in rodents. First, the functional properties of human glucose transporters expressed in brain and theircerebral locations are described. Thereafter, proposed physiological functions of GLUT1, GLUT2, GLUT3, GLUT4, andSGLT1 for energy supply to neurons, glucose sensing, central regulation of glucohomeostasis, and feeding behavior are compiled, and their roles in learning and memory formation are discussed. In addition, diseases are described in which functionalchanges of cerebral glucose transporters are relevant. These are GLUT1 deficiency syndrome (GLUT1-SD), diabetes mellitus, Alzheimer’s disease (AD), stroke, and traumatic brain injury (TBI). GLUT1-SD is caused by defect mutations in GLUT1. Diabetes and AD are associated with changed expression of glucose transporters in brain, and transporter-related energy defi-ciency of neurons may contribute to pathogenesis of AD. Stroke and TBI are associated with changes of glucose transporter expression that influence clinical outcome
Absorption of monosaccharides is mainly mediated by Na\(^+\)-d-glucose cotransporter SGLT1 and the facititative transporters GLUT2 and GLUT5. SGLT1 and GLUT2 are relevant for absorption of d-glucose and d-galactose while GLUT5 is relevant for d-fructose absorption. SGLT1 and GLUT5 are constantly localized in the brush border membrane (BBM) of enterocytes, whereas GLUT2 is localized in the basolateral membrane (BLM) or the BBM plus BLM at low and high luminal d-glucose concentrations, respectively. At high luminal d-glucose, the abundance SGLT1 in the BBM is increased. Hence, d-glucose absorption at low luminal glucose is mediated via SGLT1 in the BBM and GLUT2 in the BLM whereas high-capacity d-glucose absorption at high luminal glucose is mediated by SGLT1 plus GLUT2 in the BBM and GLUT2 in the BLM. The review describes functions and regulations of SGLT1, GLUT2, and GLUT5 in the small intestine including diurnal variations and carbohydrate-dependent regulations. Also, the roles of SGLT1 and GLUT2 for secretion of enterohormones are discussed. Furthermore, diseases are described that are caused by malfunctions of small intestinal monosaccharide transporters, such as glucose-galactose malabsorption, Fanconi syndrome, and fructose intolerance. Moreover, it is reported how diabetes, small intestinal inflammation, parental nutrition, bariatric surgery, and metformin treatment affect expression of monosaccharide transporters in the small intestine. Finally, food components that decrease d-glucose absorption and drugs in development that inhibit or downregulate SGLT1 in the small intestine are compiled. Models for regulations and combined functions of glucose transporters, and for interplay between d-fructose transport and metabolism, are discussed.
Hieracium fallax Willd. und weitere Hieracium echioides-Zwischenarten im nordwestlichen Bayern
(2007)
Die Grenze des riesigen eurasiatisch-kontinentalen Areals von Hieracium echioides Lumn. verläuft durch Mitteldeutschland, Zwischenarten aus der Hieracium echioides-Verwandtschaft (sect. Echinina) dringen westlich bis in die Oberrheinebene vor, sind aber im übrigen Süden und Südosten Deutschlands sehr selten oder fehlen. In den letzten Jahren wurden im Nordwesten Bayerns neue Wuchsorte von Hieracium auriculoides Láng (MTB 5526.31, 5924.44, 6125.13, 6223.22), H. calodon Tausch ex Peter (6123.21, 6125.13) und H. fallax Willd. (6223.21) nachgewiesen. Dies stellt den zweiten aktuellen Nachweis von H. fallax in Bayern dar, bemerkenswert ist ein Nachweis von H. auriculoides in der Rhön in ca. 700 m Meereshöhe.
In Unterfranken/Nordbayern wurde eine gut abgegrenzte Unterart der Hieracium maculatum-Gruppe festgestellt, die auf die Hänge des Maintals zwischen Würzburg und Hasloch beschränkt ist mit einem Hot Spot (>90% des Gesamtbestandes) zwischen den Orten Thüngersheim und Retzbach. Aufgrund einiger Ähnlichkeiten mit H. glaucinum subsp. prasiophaeum (Syn.: subsp. gougetianum) wird die Unterart als H. maculatum subsp. pseudogougetianum beschrieben. Diese Subspecies wächst bevorzugt auf Muschelkalk-Schotter und beginnt bereits Mitte April zu blühen, hat weißlich behaarte Kopfhüllen mit dunklen Stieldrüsen. Die Grundblattrosette besteht aus eiförmigen bis elliptischen, gezähnten bis gesägten, oberseits kahlen, glauken und dunkel gefleckten Blättern. Die Stängel tragen 1-3(4) gestielte Laubblätter und bilden meistens lange blühende Seitenäste aus den Blattachseln. H. maculatum subsp. pseudogougetianum ist wie ein Teil der H. maculatum-Sippen tetraploid mit einem Genomgewicht (2C-Wert) von 14,5 pg und unterscheidet sich damit von der H. glaucinum-Gruppe, deren untersuchte Taxa ausnahmslos triploid sind (10,1 pg).
Hieracium rotundatum subsp. silvae-bavaricae wird als neu für die Wissenschaft beschrieben und abgebildet. Die neue Unterart gehört zu einem Formenkreis von Arten (H. rotundatum, H. transylvanicum), dessen Hauptverbreitung auf dem Balkan liegt. Die wechselvolle nomenklatorische Geschichte des Artnamens wird nachgezeichnet. Diagnostische Merkmale zur Unterscheidung der in der Wuchsform ähnlichen Arten H. murorum, H. rotundatum und H. transylvanicum werden diskutiert. Dabei wird auf die Bedeutung der Ausbildung des Grundblattzyklus besonders hingewiesen. Entgegen bisheriger Kenntnis reicht die nordwestliche Verbreitungsgrenze von H. rotundatum nun bis Südost-Bayern. Bei der Suche nach H. rotundatum konnte auch eine morphologisch auffällige Unterart von H. rotundatum nachgewiesen werden, die hier als neu beschrieben wird.
Human vascular wall-resident CD44+ multipotent stem cells (VW-MPSCs) within the vascular adventitia are capable to differentiate into pericytes and smooth muscle cells (SMC). This study demonstrates HOX-dependent differentiation of CD44(+) VW-MPSCs into SMC that involves epigenetic modification of transgelin as a down-stream regulated gene. First, HOXB7, HOXC6 and HOXC8 were identified to be differentially expressed in VW-MPSCs as compared to terminal differentiated human aortic SMC, endothelial cells and undifferentiated pluripotent embryonic stem cells. Silencing these HOX genes in VW-MPSCs significantly reduced their sprouting capacity and increased expression of the SMC markers transgelin and calponin and the histone gene histone H1. Furthermore, the methylation pattern of the TAGLN promoter was altered. In summary, our findings suggest a role for certain HOX genes in regulating differentiation of human VW-MPSC into SMCs that involves epigenetic mechanisms. This is critical for understanding VW-MPSC-dependent vascular disease processes such as neointima formation and tumor vascularization.
Post-fabrication formation of a proper vasculature remains an unresolved challenge in bioprinting. Established strategies focus on the supply of the fabricated structure with nutrients and oxygen and either rely on the mere formation of a channel system using fugitive inks or additionally use mature endothelial cells and/or peri-endothelial cells such as smooth muscle cells for the formation of blood vessels in vitro. Functional vessels, however, exhibit a hierarchical organization and multilayered wall structure that is important for their function. Human induced pluripotent stem cell-derived mesodermal progenitor cells (hiMPCs) have been shown to possess the capacity to form blood vessels in vitro, but have so far not been assessed for their applicability in bioprinting processes. Here, we demonstrate that hiMPCs, after formulation into an alginate/collagen type I bioink and subsequent extrusion, retain their ability to give rise to the formation of complex vessels that display a hierarchical network in a process that mimics the embryonic steps of vessel formation during vasculogenesis. Histological evaluations at different time points of extrusion revealed the initial formation of spheres, followed by lumen formation and further structural maturation as evidenced by building a multilayered vessel wall and a vascular network. These findings are supported by immunostainings for endothelial and peri-endothelial cell markers as well as electron microscopic analyses at the ultrastructural level. Moreover, endothelial cells in capillary-like vessel structures deposited a basement membrane-like matrix at the basal side between the vessel wall and the alginate-collagen matrix. After transplantation of the printed constructs into the chicken chorioallantoic membrane (CAM) the printed vessels connected to the CAM blood vessels and get perfused in vivo. These results evidence the applicability and great potential of hiMPCs for the bioprinting of vascular structures mimicking the basic morphogenetic steps of de novo vessel formation during embryogenesis.
Iconography of the Genus Hieracium in central Europe - Part 1: General Description and Morphotypes
(2005)
The genus Hieracium comprises more than one thousand sexual and apomictic species in Europe, with numerous intermediates and microspecies. Only a small fraction of the members of the genus Hieracium has been illustrated or photo-documented in the literature. Since many of these publications are difficult to obtain, only a few specialists are familiar with most of the species and subspecies described in the literature. In order to overcome this problem and encourage geobotanical research on the genus Hieracium, we decided to edit an iconography of central and southern European Hieracia in an electronical journal (Forum geobotanicum) with free international access through the internet. Part I of this endeavour contains descriptions and photographs of the morphological spectrum of the genus Hieracium. Here, we categorize the genus into 15 basic morphotypes. These types conform partly to the sections and subsections of the genus Hieracium, but are in some cases informal and may even include members of different sections. Classification of morphotypes is considered helpful to obtain a first rough picture of an unknown species that then can be traced to the species and subspecies level by using keys or, after completion of this iconography, simply by screening the relevant images. One particularly novel aspect of the present endeavour will be the regular inclusion of magnified images and scanning electron micrographs.
The RS1 protein, a 67 kDa protein, encoded by an intronless single copy gene that was only detected in mammals, mediates transcriptional and post-transcriptional down-regulation of the sodium-D-glucose co-transporter SGLT1. The short-term post-transcriptional down-regulation of SGTL1 by RS1 has been shown to occur at the trans-Golgi network (TGN). In the present study, two tripeptides from the human RS1 protein (hRS1), GlnCysPro and GlnSerPro, that induce the post-transcriptional down-regulation of SGLT1 at the TGN, were identified. The application of the tripeptides led to 40-50% reduction of the amount of the SGLT1 protein in the plasma membrane, which correlated to the degree of decrease in SGLT1-mediated glucose transport. For the short-term down-regulation of SGLT1 by the tripeptides, the effective intracellular concentrations IC50 values of 2.0 nM (GlnCysPro, QCP) and 0.16 nM (GlnSerPro, QSP) were estimated. The observed down-regulation of SGLT1 by the tripeptides QCP and QSP, similar to hRS1 protein, was attenuated by different intracellular monosaccharides including nonmetabolized methyl-α-D-glucopyranoside and 2-deoxyglucose. On the contrary, the short-term inhibition of the hOCT2 by QCP could only be observed after rising of intracellular concentration of AMG. QCP and QSP are transported by H+-peptide cotransporter PEPT1 that is co-located with SGLT1 in the small intestinal enterocytes and thereafter effectively down-regulate hSGLT1-mediated transport of AMG. The data indicates that orally applied tripeptides QCP or QSP can be used to down-regulate D-glucose absorption in small intestine and used for treatment of obesity and diabetes mellitus.